“Dupilumab-Treated Patients With Prurigo Nodularis Report Disease Control and Treatment Satisfaction: 6-Month Results From the RELIEVE-PN Study”. 2025. SKIN The Journal of Cutaneous Medicine 9 (6): s716. https://doi.org/10.25251/h522p595.